Literature DB >> 3005968

In vitro splicing of simian virus 40 early pre mRNA.

J C Noble, C Prives, J L Manley.   

Abstract

The products of splicing of simian virus 40 early pre mRNA in HeLa cell nuclear extracts have been characterized. Of the two alternative splicing patterns exhibited by this precursor in vivo, which involve the use of alternative large T and small t 5' splice sites and a single shared 3' splice site, only one, producing large T mRNA, was found to occur in vitro. A number of possible intermediates and byproducts of splicing of large T mRNA were observed, including free large T 5' exon, lariat form intron joined to 3' exon and free lariat and linear forms of large T intron. The formation of these products argues strongly for a basic similarity in the mechanism underlying large T and other, non-alternative splices. A collection of RNAs resulting from protection of early pre mRNA at specific points from an endogenous 5' to 3' exonuclease activity in vitro have also been observed. The regions of the precursor RNA protected map to positions immediately upstream of the 5' splice sites of large T and small t and the lariat branchpoint, and may represent interaction of these regions with components of the splicing machinery.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005968      PMCID: PMC339499          DOI: 10.1093/nar/14.3.1219

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  48 in total

1.  Heterogeneity and 5'-terminal structures of the late RNAs of simian virus 40.

Authors:  P K Ghosh; V B Reddy; J Swinscoe; P Lebowitz; S M Weissman
Journal:  J Mol Biol       Date:  1978-12-25       Impact factor: 5.469

2.  Spliced early mRNAs of simian virus 40.

Authors:  A J Berk; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro.

Authors:  B Ruskin; A R Krainer; T Maniatis; M R Green
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

4.  Lariat RNA's as intermediates and products in the splicing of messenger RNA precursors.

Authors:  R A Padgett; M M Konarska; P J Grabowski; S F Hardy; P A Sharp
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

5.  A minimal intron length but no specific internal sequence is required for splicing the large rabbit beta-globin intron.

Authors:  B Wieringa; E Hofer; C Weissmann
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

6.  The 5' terminus of the RNA moiety of U1 small nuclear ribonucleoprotein particles is required for the splicing of messenger RNA precursors.

Authors:  A Krämer; W Keller; B Appel; R Lührmann
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

7.  Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate.

Authors:  P J Grabowski; R A Padgett; P A Sharp
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

8.  Elimination of mRNA splicing by a point mutation outside the conserved GU at 5' splice sites.

Authors:  C Montell; A J Berk
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

9.  Splicing pathways of SV40 mRNAs in X. laevis oocytes differ in their requirements for snRNPs.

Authors:  A Fradin; R Jove; C Hemenway; H D Keiser; J L Manley; C Prives
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

10.  U1 RNA-protein complex preferentially binds to both 5' and 3' splice junction sequences in RNA or single-stranded DNA.

Authors:  K Tatei; K Takemura; A Mayeda; Y Fujiwara; H Tanaka; A Ishihama; Y Ohshima
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more
  22 in total

1.  Analysis of spliceosome assembly and the structure of a regulated intron in Drosophila in vitro splicing extracts.

Authors:  D Spikes; P M Bingham
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  The simian virus 40 small-t intron, present in many common expression vectors, leads to aberrant splicing.

Authors:  M T Huang; C M Gorman
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

3.  A 5'----3' exoribonuclease of human placental nuclei: purification and substrate specificity.

Authors:  A Stevens; M K Maupin
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

4.  The pre-mRNA 5' cap determines whether U6 small nuclear RNA succeeds U1 small nuclear ribonucleoprotein particle at 5' splice sites.

Authors:  L O'Mullane; I C Eperon
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

5.  Factor interactions with the simian virus 40 early pre-mRNA influence branch site selection and alternative splicing.

Authors:  J C Noble; H Ge; M Chaudhuri; J L Manley
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  Requirements for accurate and efficient mRNA 3' end cleavage and polyadenylation of a simian virus 40 early pre-RNA in vitro.

Authors:  L C Ryner; J L Manley
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

7.  The natural 5' splice site of simian virus 40 large T antigen can be improved by increasing the base complementarity to U1 RNA.

Authors:  Y Zhuang; H Leung; A M Weiner
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

8.  A 5' exo-ribonuclease and RNA ligase of T. brucei.

Authors:  J Huang; L H Van der Ploeg
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

9.  Oligonucleotide-targeted degradation of U1 and U2 snRNAs reveals differential interactions of simian virus 40 pre-mRNAs with snRNPs.

Authors:  Z Q Pan; H Ge; X Y Fu; J L Manley; C Prives
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

10.  Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient.

Authors:  Els van der Meijden; René W A Janssens; Chris Lauber; Jan Nico Bouwes Bavinck; Alexander E Gorbalenya; Mariet C W Feltkamp
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.